KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Total Non-Current Liabilities (2018 - 2025)

Castle Biosciences' Total Non-Current Liabilities history spans 7 years, with the latest figure at $106.2 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 40.83% year-over-year to $106.2 million; the TTM value through Dec 2025 reached $106.2 million, up 40.83%, while the annual FY2025 figure was $106.2 million, 40.83% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $106.2 million at Castle Biosciences, up from $94.2 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $106.2 million in Q4 2025 and bottomed at $22.0 million in Q3 2021.
  • The 5-year median for Total Non-Current Liabilities is $48.1 million (2022), against an average of $56.6 million.
  • The largest annual shift saw Total Non-Current Liabilities skyrocketed 103.05% in 2022 before it fell 11.28% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $32.5 million in 2021, then skyrocketed by 47.76% to $48.1 million in 2022, then grew by 29.02% to $62.0 million in 2023, then rose by 21.52% to $75.4 million in 2024, then soared by 40.83% to $106.2 million in 2025.
  • Per Business Quant, the three most recent readings for CSTL's Total Non-Current Liabilities are $106.2 million (Q4 2025), $94.2 million (Q3 2025), and $87.9 million (Q2 2025).